| Clopidogrel improves microcirculation in ST-elevation myocardial infarction (STEMI) treated with fibrinolytics, when compared with placebo. |
| In acute coronary syndrome, ticagrelor is superior to clopidogrel in terms of hard endpoint incidences. |
| We analyzed the effect of ticagrelor or clopidogrel on coronary microcirculation in patients presenting with STEMI. |
| Despite lower platelet reactivity with ticagrelor, in comparison with clopidogrel, there is no difference between the effect of the drugs on coronary microcirculation in patients with STEMI treated with fibrinolytics. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.